Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Psoriasis 4Lymphoma, Follicular 4Uveitis 1Pruritus 1Pneumonia 1Plaque, Amyloid 1Cachexia 1Bronchiolitis Obliterans Syndrome 1Arthritis, Rheumatoid 1Arthritis, Juvenile 1Anorexia 1

Interventions

tofacitinib 7Imatinib Mesylate 5ibrutinib 3ofatumumab 2nilotinib 2ruxolitinib 1canakinumab 1bosutinib 1Sirolimus 1Rituximab 1Proto-Oncogene Proteins c-raf 1Photopheresis 1Pentostatin 1Mycophenolic Acid 1Methotrexate 1Infliximab 1Everolimus 1Etanercept 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Bronchiolitis Obliterans Syndrome × Etanercept × Clear all
NCT01241591 2018-12-26

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Pfizer

Phase 3 Completed
1,101 enrolled 46 charts
Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis, Plaque, Amyloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡